Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra Carter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Population Health Management|April 25, 2026
Rethinking Blood Pressure Quality Measurement: Accounting for Seasonal Variation in Value-Based CareJennifer Stephens, Debra Carter, Beth Careyva, et al.
Journal of Leukocyte Biology|July 30, 2003
Control of myeloid activity during retinal inflammationAndrew D Dick, Debra Carter, Morag Robertson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With FibrosisSudha S Shankar, Samuel J Daniels, Darren Robertson, et al.
Circulation. Cardiovascular Imaging|August 7, 2015
Mechanistic Insights into Sympathetic Neuronal Regeneration: Multitracer Molecular Imaging of Catecholamine Handling After Cardiac TransplantationPaco E Bravo, Riikka Lautamäki, Debra Carter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2025
A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non-Cirrhotic Metabolic Dysfunction-Associated SteatohepatitisJavier Armisen, Armando Flor, John Eriksson, et al.
Diabetes Care|June 9, 2022
Once-Weekly Exenatide in Youth With Type 2 DiabetesWilliam V Tamborlane, Raafat Bishai, David Geller, et al.
Journal of the American College of Cardiology|April 1, 2025
An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized TrialMichael J Koren, Rick B Vega, Nikhil Agrawal, et al.
Transplantation|October 13, 2022
COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron SurgeWilla Cochran, Sonsoles Salto-Alejandre, Lindsay Barker, et al.
ESC Heart Failure|December 25, 2021
Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experiencePaul J Scheel, Katherine Giuliano, Crystal Tichnell, et al.
Circulation|May 15, 2026
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive PatientsRick B Vega, Gavin O'Mahony, April M Barbour, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Population Health Management|April 25, 2026
Rethinking Blood Pressure Quality Measurement: Accounting for Seasonal Variation in Value-Based CareJennifer Stephens, Debra Carter, Beth Careyva, et al.
Journal of Leukocyte Biology|July 30, 2003
Control of myeloid activity during retinal inflammationAndrew D Dick, Debra Carter, Morag Robertson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With FibrosisSudha S Shankar, Samuel J Daniels, Darren Robertson, et al.
Circulation. Cardiovascular Imaging|August 7, 2015
Mechanistic Insights into Sympathetic Neuronal Regeneration: Multitracer Molecular Imaging of Catecholamine Handling After Cardiac TransplantationPaco E Bravo, Riikka Lautamäki, Debra Carter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2025
A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non-Cirrhotic Metabolic Dysfunction-Associated SteatohepatitisJavier Armisen, Armando Flor, John Eriksson, et al.
Diabetes Care|June 9, 2022
Once-Weekly Exenatide in Youth With Type 2 DiabetesWilliam V Tamborlane, Raafat Bishai, David Geller, et al.
Journal of the American College of Cardiology|April 1, 2025
An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized TrialMichael J Koren, Rick B Vega, Nikhil Agrawal, et al.
Transplantation|October 13, 2022
COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron SurgeWilla Cochran, Sonsoles Salto-Alejandre, Lindsay Barker, et al.
ESC Heart Failure|December 25, 2021
Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experiencePaul J Scheel, Katherine Giuliano, Crystal Tichnell, et al.
Circulation|May 15, 2026
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive PatientsRick B Vega, Gavin O'Mahony, April M Barbour, et al.
Pageof 1